CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Renalytix Fiscal Q2 2023 Earnings Report - CapyFin

Renalytix

RNLXY · LSE-AIM🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q1 2025 -8.11%Q4 2024 -8.11%Q3 2024 -4.08%Q2 2024 -37.36%Q1 2024 +3.31%Q2 2023 -21.94%Q4 2023 -21.94%Q3 2023 -5.71%Q1 2023 +13.79%Q4 2022 +6.67%Q3 2021 -37.31%Q3 2022 -37.31%Q1 2022 -9.09%Q2 2022 -9.09%Q4 2021 -0.67%Q4 2020 -0.85%

Sep 28, 2023

•

Dec 31, 2022

Renalytix Q2 2023 Earnings Report

Previous year: $845K

Previous year: -$0.21

Previous year: $353K

Cash and Equivalents

Previous year: $39.9M

Previous year: -$14.3M

Previous year: $54.4M

Renalytix

Unlock previous datapoints

Renalytix

Unlock previous datapoints

Revenue by Segment

KidneyIntelX Revenue

CapyFin.com

Pharmaceutical Services Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

Renalytix Revenue by Segment